Every 8-K that Innospec Inc. (IOSP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow IOSP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IOSP filings page.
Innospec Inc. reported solid second-quarter 2026 results with broad-based growth across all segments. Total revenue was $491.4 million, up 12 percent from $439.7 million a year earlier. Net income attributable to Innospec rose to $30.8 million, and diluted GAAP EPS increased to $1.25 from $0.94. Adjusted non-GAAP EPS was $1.27, slightly above $1.26 last year, while adjusted EBITDA was $50.1 million versus $49.1 million.
Performance Chemicals revenue grew 9 percent to $190.3 million with operating income up 15 percent. Fuel Specialties revenue increased 12 percent to $185.7 million, and Oilfield Services revenue rose 14 percent to $115.4 million, with operating income in that segment up 40 percent. The quarter ended with a debt‑free balance sheet and $250.2 million in cash and cash equivalents. Operating cash flow for the quarter was $7.2 million. Innospec returned capital through a semi‑annual dividend of $0.92 per share (about $22.7 million) and share repurchases of 87,089 shares for $6.4 million.
Innospec Inc. reported a change in its Board of Directors. Effective June 2, 2026, the Board increased its size from seven to eight members and appointed Shelley Bausch as a Class II director, starting July 1, 2026 and serving until the 2027 annual stockholder meeting or until a successor is elected and qualified.
She will also join the Audit Committee on July 1, 2026. As a non-employee director, Ms. Bausch will receive a standard annual cash retainer of $100,000, plus an additional annual $5,000 for Audit Committee service, both paid quarterly. She will be eligible for an annual equity grant with an expected value of $125,000 under the company’s Long-Term Incentive Omnibus Plan, similar to awards granted in February 2025, which vest after three years. She may also earn $2,000 per additional day for extra services at the CEO’s request, and the company states there are no related-party transactions requiring disclosure.
Innospec Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 8, 2026. As of the March 13, 2026 record date, 24,890,467 shares of common stock were outstanding and entitled to vote, and 22,661,185 shares were present or represented by proxy, about 91% of eligible shares.
Stockholders re-elected Class I directors Elizabeth K. Arnold and Claudia P. Poccia. They also approved the advisory vote on executive compensation and ratified the appointment of the company’s independent registered public accounting firm for 2026, based on the final certified vote results.
Innospec Inc. reported first-quarter 2026 revenue of $453.2 million, up 3% from $440.8 million a year earlier, while GAAP diluted EPS declined to $1.22 from $1.31. Adjusted non-GAAP EPS fell to $1.05 from $1.42 as margins weakened in certain segments.
Performance Chemicals revenue rose slightly to $169.4 million, but operating income dropped 46% to $10.7 million, reflecting impacts from a U.S. winter storm. Fuel Specialties delivered another solid quarter with revenue of $181.6 million, up 7%, and operating income of $37.8 million, up 2%. Oilfield Services revenue was stable at $102.2 million, with operating income improving 37% to $5.6 million.
The company ended the quarter with $289.1 million in cash and no debt. The board increased the semi-annual dividend by 10% to $0.92 per share, payable May 29, 2026, and authorized a new $75 million share repurchase program over three years, replacing a prior $50 million authorization.
Innospec Inc. reported mixed fourth-quarter and full-year 2025 results, with solid profitability but lower sales and underlying earnings. Fourth-quarter revenue was $455.6 million, down 2%, while net income swung to a profit of $47.4 million, or $1.91 per diluted share, compared with a prior-year loss driven by a UK pension buyout charge. Adjusted non-GAAP EPS rose to $1.50 from $1.41, and adjusted EBITDA was essentially flat at $55.7 million.
For 2025, revenue declined 4% to $1.78 billion and adjusted EBITDA fell 10% to $203.0 million. Full-year net income improved to $116.6 million, or $4.67 per diluted share, largely reflecting the absence of the prior-year UK pension scheme settlement. However, adjusted non-GAAP EPS decreased to $5.27 from $5.92, showing softer underlying performance.
Fuel Specialties was a bright spot, with 2025 operating income up 12% to $144.8 million, while Performance Chemicals and Oilfield Services saw lower annual operating income. Cash generation remained strong: operating cash flow was $138.3 million for the year, and Innospec ended 2025 with net cash of $292.5 million, giving it balance sheet flexibility for dividends, buybacks, investment and M&A.
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.